Awan, F. T., Schuh, A., Brown, J. R., Furman, R. R., Pagel, J. M., Hillmen, P., . . . Byrd, J. C. (2019). Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib. Blood Adv.
Citação norma ChicagoAwan, Farrukh T., et al. "Acalabrutinib Monotherapy in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Ibrutinib." Blood Adv 2019.
MLA引文Awan, Farrukh T., et al. "Acalabrutinib Monotherapy in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Ibrutinib." Blood Adv 2019.
警告：這些引文格式不一定是100％准確.